More patients than ever are seeking treatment for symptomatic internal hemorrhoids.
The best solution is the Redfield IRC2KMT Infrared Coagulator.

Infrared coagulation really works
For more than twenty years, scores of scientific papers and texts conclude that nothing works better to reduce the bleeding and occasional discomfort of non-prolapsing symptomatic internal hemorrhoids than infrared coagulation.

Patients prefer Infrared Coagulation
With more patients undergoing colonoscopy, more internal hemorrhoids are being diagnosed. While surgery is sometimes indicated, the majority of patients are ideal candidates for infrared coagulation. Faced with surgery, which can require up to four weeks of recovery time, or infrared coagulation, which allows patients to return to normal activities almost immediately, most patients choose infrared coagulation.

Treatment with the IRC2100™
Infrared Coagulation of hemorrhoids is easy to learn. A sterile, disposable sheath is placed over the lightguide. The anoscope is inserted and the lightguide is placed in direct contact with the mucosa at the base of the hemorrhoid. Three to five exposures of about 1.5 seconds are applied in a semi-circular pattern. Depth of coagulation is determined by the pre-set auto-timer. With each exposure, instantaneous coagulation occurs without smoke or odor. A small, whitish, circular eschar can be observed. Within 2-3 weeks, the hemorrhoid returns to its normal size and position. Most physicians treat one hemorrhoidal quadrant per visit and allow three-week intervals between treatments.

Remarkably safe and effective
Infrared coagulation has a remarkable safety record. Complications are rare and usually limited to minor bleeding. There have been no reported incidents of sepsis or stricture.

Other IRC2100™ applications
IRC2100™ is also indicated for tattoo removal, condyloma acuminata, common warts, and chronic rhinitis due to turbinate hypertrophy. The IRC2100™ can coagulate even in a wet field and is ideal for achieving post-biopsy hemostasis and donor site coagulation in hair restoration procedures. Applications under investigation include treatment of squamous intraepithelial lesions, and benign cervical, vulvar and vaginal lesions.